HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,569,000 | -50.8% | 100,000 | -56.2% | 0.06% | -48.3% |
| Q2 2023 | $23,500,711 | -5.8% | 228,495 | 0.0% | 0.12% | -4.9% |
| Q1 2023 | $24,937,944 | +287.5% | 228,495 | +304.0% | 0.12% | +306.7% |
| Q4 2022 | $6,436,300 | -58.7% | 56,558 | -60.9% | 0.03% | -48.3% |
| Q4 2021 | $15,579,000 | +79.1% | 144,567 | +82.0% | 0.06% | +52.6% |
| Q3 2021 | $8,699,000 | +73.1% | 79,416 | +47.9% | 0.04% | +65.2% |
| Q2 2021 | $5,026,000 | +185.7% | 53,678 | +180.8% | 0.02% | +130.0% |
| Q1 2021 | $1,759,000 | +21.3% | 19,114 | -3.6% | 0.01% | +25.0% |
| Q4 2020 | $1,450,000 | +5.1% | 19,826 | +11.7% | 0.01% | -11.1% |
| Q3 2020 | $1,379,000 | +111.8% | 17,751 | +51.5% | 0.01% | +80.0% |
| Q2 2020 | $651,000 | +34.2% | 11,713 | -12.6% | 0.01% | +150.0% |
| Q4 2019 | $485,000 | +32.9% | 13,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $365,000 | +13.4% | 13,400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $322,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |